Topic:

Personalized Medicine

Latest Headlines

Latest Headlines

Telomerase study points researchers to targeted cancer drugs

Researchers at the University of Illinois at Urbana-Champaign and at the University of California, San Francisco, have been delving into the mechanisms by which mutations result in elevated expression of the protein called telomerase.

Japan drugmakers steal a march on nucleic acid-based treatments

SINGAPORE-- Several Japan drugmakers are making strides toward being major pioneers in the new pharmaceuticals field of nucleic acid-based treartments. A few already have clinical trials in the works for such things as Duchenne muscular dystrophy.

Obama puts personalized medicine in the spotlight with a primetime pitch

Speaking before a global audience of millions, President Barack Obama threw his support behind the potential of personalized medicine, skimping on details but hinting at a federally funded R&D effort in keeping with the $4.5 billion BRAIN Initiative.

Venrock unveils a $450M new fund with eyes on biotech

Well-heeled venture capital firm Venrock has pieced together a 7th fund, banking $450 million in new investments as it sets out to grow its portfolio of promising startups.

Northwest Bio shoots for dendritic success where others have failed

Bethesda, MD's Northwest Biotherapeutics has watched as rivals Dendreon and ImmunoCellular have run into serious roadblocks with personalized cancer vaccines over the past year, but with a major Phase III study underway, the biotech believes it can change the narrative.

BioLineRx shows effectiveness of leukemia drug in preclinical study

Israel's BioLineRx has unveiled positive preclinical data for its experimental treatment for chronic myeloid leukemia, a progressive blood and bone marrow cancer.

Targeting 'undruggable' cancer mechanism can make chemo more effective, study says

Researchers have found a possible new way to treat cancer by exploiting a biological weakness in the most commonly mutated gene involved in human cancers.

Discovery links genes to excess belly fat

New genes identified by scientists at the University of Louisville in Kentucky may indicate a person's predisposition to excess abdominal fat, which can be an indicator of more serious health conditions, such as cardiovascular disease, Type 2 diabetes and cancer.

Industry Voices: Inside Genomics--Q&A with Bina CEO Narges Bani Asadi and Dr. Ralph Snyderman

One of the elements lacking in the personalized medicine discussion today is the perspective of leading clinicians, informaticists and academics working in the field. To remedy the gap, I've asked a series of leaders in the industry to offer up their views.

Researchers find possible drug targets for undruggable melanomas

Researchers at Vanderbilt University have discovered promising drug targets for previously hard-to-treat kinds of melanoma, suggesting that some cancers believed not to have such targets actually do.